To further elucidate the capacity of our approach, we have also clustered datasets where no clustering approach has been applied so far.
Future research should focus on validating the current model using a larger data set, comparing lipid filled SPMDs to nonlipid filled samplers that employ performance reference compounds, evaluating the predictive capacity of the approach in other aquatic biota and tissue types, and extending the approach to additional contaminants that drive risk assessments.
Results obtained on both small benchmark social network and on clustering problems argue for the capacity of the approach to detect real communities.
We selected a multidrug resistant clinical isolate in order to check the capacity of our approach to identify selected protein markers.
However, the capacity of this approach to accurately detect a range of striatal DAT levels in the most widely used animal model of PD, i.e., the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP -treated MPTP -treateds to be determouse.
Our observations of CTT proteins in association with biological and biochemical pathways that may be uniquely vertebrate, e.g. neural crest formation and most organogenesis pathways, highlight the significant capacity of this approach to further understand clinically relevant developmental processes.
To determine the capacity of this approach for the high-throughput generation of phage sequences, we produced insert-containing amplicons from surgical biopsies of four human tissues (skin, white adipose tissue, bone marrow, and skeletal muscle), with oligonucleotides flanking the DNA insert coding for the peptide in the pIII gene (Fig. 1A).
Increasing the number of subjects may possibly help to further improve the discrimination capacity of our approach, as discussed below.
Here, the RTP values have been obtained from predictions within the leave-one-out cross-validation and are therefore an indicator of the generalization capacity of our approach.
